Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 141,334,736
  • Shares Outstanding, K 5,666,990
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • EBIT $ 10,649 M
  • EBITDA $ 16,939 M
  • 60-Month Beta 0.67
  • Price/Sales 2.43
  • Price/Cash Flow 8.43
  • Price/Book 1.54

Options Overview Details

View History
  • Implied Volatility 25.73% ( -1.38%)
  • Historical Volatility 21.97%
  • IV Percentile 53%
  • IV Rank 52.05%
  • IV High 32.70% on 04/12/24
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.92
  • Today's Volume 265,777
  • Volume Avg (30-Day) 212,639
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 3,349,326
  • Open Int (30-Day) 3,081,921

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.49
  • Number of Estimates 7
  • High Estimate 0.65
  • Low Estimate 0.39
  • Prior Year 0.10
  • Growth Rate Est. (year over year) +390.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.48 +2.66%
on 11/15/24
29.17 -13.85%
on 10/29/24
-3.80 (-13.14%)
since 10/21/24
3-Month
24.48 +2.66%
on 11/15/24
30.43 -17.42%
on 10/09/24
-3.90 (-13.43%)
since 08/21/24
52-Week
24.48 +2.66%
on 11/15/24
31.54 -20.32%
on 07/30/24
-5.17 (-17.06%)
since 11/21/23

Most Recent Stories

More News
The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair

For Immediate ReleaseChicago, IL – November 21, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

DG : 73.92 (+0.89%)
ADBE : 504.44 (+0.99%)
SNAP : 10.63 (+0.38%)
RYAAY : 42.88 (-2.41%)
PFE : 25.13 (+0.76%)
Pfizer Names New Head Of Research And Development

Pharmaceutical giant Pfizer (PFE) has named company veteran Chris Boshoff its chief of research and ...

PFE : 25.13 (+0.76%)
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist

Every company faces challenges. Sometimes, those issues are deeply damaging to a corporation's investment thesis. Other times, though, that's not the case, and the price drop represents a great buying...

MRK : 99.86 (+2.48%)
PFE : 25.13 (+0.76%)
2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years

Collecting an above-average dividend payment can sometimes come with risks. High-yielding stocks can be due for cuts to their payouts if a company's underlying financials aren't strong enough to support...

VZ : 42.50 (+0.66%)
PFE : 25.13 (+0.76%)
5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential

U.S. stock markets have been witnessing an impressive rally since the beginning of 2023 barring some minor hurdles. Wall Street’s bull run has got an added boost this year, to the surprise of a large...

DG : 73.92 (+0.89%)
ADBE : 504.44 (+0.99%)
SNAP : 10.63 (+0.38%)
RYAAY : 42.88 (-2.41%)
PFE : 25.13 (+0.76%)
Is It Time to Sell Eli Lilly and Pfizer Stocks?

Arguably, no big pharma stocks have dominated the industry more over the last few years than Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE) .

LLY : 749.92 (-0.46%)
PFE : 25.13 (+0.76%)
The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and Qualcomm

For Immediate ReleaseChicago, IL – November 19, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

QCOM : 155.46 (+0.77%)
NEM : 43.32 (+0.77%)
ADBE : 504.44 (+0.99%)
UBER : 69.64 (+0.06%)
PFE : 25.13 (+0.76%)
TAHO Pharmaceuticals Initiates U.S. Phase III Clinical Trial of TAH3311 Antithrombotic Oral Dissolving Film, Dosing First Subjects

/CNW/ -- TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product, TAH3311, an innovative...

PFE : 25.13 (+0.76%)
Top Analyst Reports for Thermo Fisher, NextEra Energy & Lowe's

Monday, November 18, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher...

SHOP : 106.48 (+2.44%)
LOW : 265.22 (+0.83%)
TMO : 516.10 (+0.64%)
SCHW : 80.80 (+0.42%)
PFE : 25.13 (+0.76%)
NEE : 77.36 (+0.62%)
Stock market today: Wall Street rises following last week's slide

Most U.S. stocks ticked higher to recover some of their sharp slide from last week

NVDA : 146.67 (+0.53%)
CVS : 57.10 (+0.48%)
LOW : 265.22 (+0.83%)
$SPX : 5,948.71 (+0.53%)
$DOWI : 43,870.35 (+1.06%)
SAVE : 1.0200 (-5.56%)
LBRT : 18.35 (+4.44%)
MRNA : 38.25 (+3.55%)
$IUXX : 20,740.78 (+0.36%)
PFE : 25.13 (+0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 25.75
2nd Resistance Point 25.48
1st Resistance Point 25.31
Last Price 25.13
1st Support Level 24.86
2nd Support Level 24.60
3rd Support Level 24.42

See More

52-Week High 31.54
Fibonacci 61.8% 28.84
Fibonacci 50% 28.01
Fibonacci 38.2% 27.18
Last Price 25.13
52-Week Low 24.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar